Clinical Trial

Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment

Name: Colistin Versus Colistin Combined With Cefoperazone-sulbactam for Multiresistant Acinetobactor Baumannii Ventilator-associated Pneumonia Treatment — clinical trial record (NCT07671755)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CRAB

Completed

View on ClinicalTrials.gov →

Summary

This study aims to evaluate clinical outcomes of colistin versus colistin in combination with cefoperazone-sulbactam for patients with MDR-AB VAP treatment.

Trial Details

NCT Number	NCT07671755
Lead Sponsor	Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Conditions	Clinical Response, Radiological Response
Enrollment	80 participants
Start Date	2025-02-01
Primary Completion	2025-12-30 (estimated)
Study Completion	2026-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-26